chrisvoncsefalvay/vaers-outcomes huggingface dataset:
raised bumps on torso from neck to butt, about 10 of them, when run finger over them they sting for a few seconds; also dizzy last night; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 46-years-old non-pregnant female patient received BNT162B2 (BNT162B2) via an unspecified route of administration, in left arm on 13Feb2021 at 17:15  as single dose for COVID-19 immunization at the age 46 years. Medical history included hypothyroidism and osteoarthritis. Concomitant medication(s) included Synthroid. No known allergies were reported. Patient did not receive any other vaccines in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID-19. On 20Feb2021, patient experienced raised bumps on torso from neck to butt, about 10 of them, when run finger over them they stung for a few seconds, also dizzy last night and investigated bed bugs or mites but haven't found evidence of them. No treatment was received for the events. Outcome of the events was not recovered.
COVID-related hospitalization after receiving Pfizer series + booster (10/21/2021, 2/12/2021, 1/21/2021)   Pfizer  Vaccines: 10/21/2021 Right arm, lot 32030BD  2/12/2021 left deltoid, lot EL9264  1/21/2021 Right deltoid, lot EL3249    Admitted 4/17/2022  Discharged 4/28/2022   Per hospital notes:  Admitted to the hospital for generalized weakness and fatigue. Symptoms chronic, ongoing for 2 months, but worsening due to covid-19.  Tested positive for covid 4/17/22  Chest x-ray: no acute findings  Received monoclonal antibody (bebtelovimab) on 4/18   Patient found to have a UTI during admission and Rocephin started 4/23/22, de-escalated to Keflex.   Symptoms improved prior to discharge.
Headache, nausea, hacking cough, hives, swollen, red and puffy eyes until mid-day on 1/12/2013.  Called Dr. morning of 01/11/2013 due to symptoms; Dr. was not convinced symptoms were related to flu vaccine, yet symptoms suddenly appeared after vaccination and stopped shortly after receiving vaccine.
Per records - Patient presented to ER with complaints of chest pain that started 9/12/21, worse at bedtime. Admitted to hospital for observation. Per Post COVID vaccine myocarditis pathway patient treated with 1 dose IVIG on 09/22/21 and 1IV Solumedrol. At time of discharge patient her usual state of health w/out complaints of headache, nausea, and was afebrile, tolerating good PO intake.
Womens health changes I had had an IUD for 1.5 years NO complications until the vaccine. A month after 11/21 until today 08/22 Every MONTH I now experience Menstrual bleeding  1-2 weeks long, blood clots from pin needle to nickle size, (MIND YOU, I HAVE AN IUD) uterine tissue shedding and globules, immense pelvic pain, back pain, headaches and fatigue. I NEVER EVER HAD THESE ISSUES PRIOR TO. I had Nexplanon for 5 years before the IUD and NEVER had a period or any cramping, clots etc. i have seen a OBGYN almost every other month due to complications and changes to my menstruation,  reproductive health and hormonal imbalances! I had to try a oral pill along WITH the IUD to help the bleeding but had to stop because it caused high blood pressure from too must estrogen. This is TERRIBLE!
Pt recvd MMR vax & c/o itching during p/school program w/red blotches starting on back radiating  to chest per grandmother's report; @ 630PM rash moved to head, neck w/flushing no6ed on body taken to ER given Epi & DPH;
No additional AEs; an expired dose of PNEUMOVAX 23 was administered on 11/08/2022; This spontaneous report was received from a pharmacy technician and refers to a patient of unknown gender and age. There was no information about the patient's pertinent medical history, concomitant medications or drug reactions and allergies.  On 08-NOV-2022, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) prefilled syringe, injection, lot U010533, expiration date 29-OCT-2022 (exact dose, route of administration and anatomical location were not reported) for prophylaxis (Expired product administered). No additional adverse events were reported (No adverse event).
right arm tingling;  dissapated without treatment in 3 mins. time.   waiting 15 mins.  suggested time & driver drove off lot.
4 hours after Influenza vaccine developed puritic rash on buttocks in distribution of where Aspercream was being used for buttocks pain. Lesion raised, blanching,...midline. Shot in arm. No lesion hives. Possible contact reaction to Aspercream. Tolerated for year prior to shot.
This spontaneous report as received from a consumer reporting to her daughter a 17 weeks old female patient with no drug reactions or allergies and no pertinent medical history who on 15-JAN-2013, was vaccinated with a dose 1 ROTATEQ (lot # not provided). No other co-suspects were reported. No concomitant medications were reported. The patient's mother stated that the patient was given the first dose of ROTATEQ at 17 weeks of age instead of the indicated 6-12 weeks of age and the patient developed a high fever shortly after receiving ROTATEQ. The patient did not sought medical attention and was treated with TYLENOL. No further AE information was provided. the outcome of the patient high fever was reported as recovering/resolving. The relatedness for high fever was unknown for ROTATEQ. Additional information has been requested.
Patient received flu vaccine on 11/1 afternoon.  One hour later experienced fleeting nausea.  That same evening after dinner around 7pm, pt had nauasea & vomited once.  At 1am on 11/2, pt woke up vomiting.  She was hospitalized 11/2 to 11/3.  Pt reported chills, had fever 101-103F.  Head CT, CXR & abd X ray were done to R/O obstruction, which were all negative.  Pt was pancultured, and given a dose of IV cefotaxime.  Pt tolerated liquid diet, was ambulating & afebrile on day of discharge.  Pt was discharged on PO Cipro for possible urosepsis.  Final blood & urine cultures all negative.  Pt had no further F/C/N/V.  2/16/07 Received medical records from hospital which reveal patient admitted 11/2-11/3/06 after experienced one day history of malaise, N/V, fevers & chills. Also complained of chest pain radiating to neck intermittently x 1-2 wks.  Temp in ER 101 & was pan cultured.  Tx w/IV antibiotics.  Improved & was d/c home to continue oral antibiotics. FINAL DX: febrile illness w/dysuria, possible UTI vs cystitis.
Dizzy; could not drink or eat properly for the whole weak; Dehydrated; UTI; diarrhea; Nauseous; Chills; Fever high upto 102 degree; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEEDING DISORDER (could not drink or eat properly for the whole weak), DEHYDRATION (Dehydrated), URINARY TRACT INFECTION (UTI) and DIARRHOEA (diarrhea) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 319B21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced DIZZINESS (Dizzy), FEEDING DISORDER (could not drink or eat properly for the whole weak), DEHYDRATION (Dehydrated), URINARY TRACT INFECTION (UTI), DIARRHOEA (diarrhea), NAUSEA (Nauseous), CHILLS (Chills) and PYREXIA (Fever high upto 102 degree). At the time of the report, DIZZINESS (Dizzy), FEEDING DISORDER (could not drink or eat properly for the whole weak), DEHYDRATION (Dehydrated), URINARY TRACT INFECTION (UTI), DIARRHOEA (diarrhea), NAUSEA (Nauseous), CHILLS (Chills) and PYREXIA (Fever high upto 102 degree) was resolving. Not Provided          Concomitant medication information was not reported. Treatment include antibiotics
A week after my shot I started developing hives and severe wheezing. As if I had come into contact with something I was allergic to. I have had this going on now for over 3 months and have had lab work done to check my blood for any possible reason why. Nothing came back.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0011521A) for COVID-19 vaccination.     No Medical History information was reported.  On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   Concomitant medications included blood pressure medication and cholesterol medication not in high doses.  No treatment information was provided.   This case was linked to MOD-2021-331695 (Patient Link).
pt rcvd vax; pt exp jt stiffness, pain in eyes, hives on eyelids, dizziness & nausea; w/ 2nd dose pt exp swelling, stiffness & pain in jts, fatigue, & flushing & hives on face & eyelids; w/3rd dose inc in all symptoms;
Narrative: Patient received a dose of the Pfizer COVID-19 vaccine on 05/26/2021 at pharmacy #9232 and the a dose of the Moderna COVID-19 vaccine on 06/02/2021 at the pharmacy # 15363. Patient incorrectly received two different manufacturers at a shorter than recommended interval.
bradycardia, pt became pale, nauseated shortly p/vax were given; Epi given;
In the evening patient stated she felt itching to arms and had swelling to lips and around mouth.
Information has been received from a physician via a field representative. The reporter totally reported 4 patients of unknown age and gender: 2 were teenagers, 1 baby and 1 child whose age could not be determined but was described as immunocompromised. It was reported that one of the 4 patients received 2 doses of VARIVAX (Merck). The immunocompromised patient had only one dose of VARIVAX (Merck). The dose for the other 2 patients was unspecified. It was reported that 3 out of the 4 patients each developed shingles, including the immunocompromised child; the fourth patient developed unspecified reaction to the vaccine (it was unspecified what specific symptoms or reaction the patient developed, however the patient did developed). The physician did not define how long past the VARIVAX (Merck) the adverse events happened. One of the adverse events happened in December 2015 and another in February 2016. The time of the other 2 adverse events was unspecified. This report referred to 2 out of the 3 patients who developed shingles (the immunocompromised child who developed shingle was captured in MAARS# 1603USA005974). This is one of several cases reported from the same reporter. Additional information has been requested.
Person was disoriented. Confused. Did not know where he was at , hallucination , thought people were in the room when the were not
My father developed a severe headache on the evening of 3/15,  followed by left sided facial paralysis, facial droop approximately 7 days after receiving the  first dose of the COVID-19 vaccine at a CVS pharmacy.  He was admitted to hospital on 3/16 for acute stroke workup given his VERY CLEAR Facial droop, slurred speech. His CT  Head was negative for acute bleed and his MRI Brain was negative for any acute stroke. He was seen by Neurologist while inpatient and was determined to have Bell Palsy and NOT an acute or subacute stroke.   Prior to taking the vaccine, he had NO facial droop. After taking the vaccine, he received no new medications nor did he travel to any other places. Additionally, he lives in a city and has not been hiking in the woods.
Information has been received from an RN concerning a male who was vaccinated with Hep-B. Six weeks, post vax, the pt experienced loss of all of his hair. Medical attention was sought. Follow-up information from an RN indicated that "nothing happened to our pt". No further information is available.
Fever, chills, nausea, itchy rash on stomach neck chest back, swelling of lymph node of left arm, aches. Took Tylenol and Benadryl.
Headache, Myalgia, Arthralgia,  ABDOMINAL PAIN Narrative:
After patient received her 2nd COVID booster this afternoon, patient was asked to wait in recovery for 15 minutes. At approximately 3:15 this patient reported a swelling of her bottom lip and a "scratchy" throat. The nurse manager was notified, patient was assessed, and 25mg Benadryl PO were given to the patient. Patient's family member/caretaker and patient verbalized understanding of education and plan: Patient is to go home with escort, patient understands that she may feel drowsy but the medication will help with the reaction, and patient is to call us back if any questions or concerns. Patient will be called in one hour from leaving vaccine clinic.
Very weak the following day/leg weakness; Nausea; leg weakness; Temp 99.3; difficulty ambulating; Woke up during the night with chills; This is a spontaneous report from a contactable consumer (Patient). A 74-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via intramuscularly, administered in left arm (deltoid) on 16Feb2021 at 10:30 AM (age at the time of vaccination: 74-year-old) as DOSE 1, SINGLE for COVID-19 immunization. Patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9262) via intramuscularly, administered in left deltoid on 09Mar2021 at 09:30 AM as DOSE 2, SINGLE for COVID-19 immunization. Medical history included COVID 19. Patient had no allergies. Concomitant medications included vitamin C [ascorbic acid], colecalciferol (VITAMIN D [COLECALCIFEROL]), flaxseed oil [linum usitatissimum seed oil] and probiotics. On 17Feb2021 01:00 AM, patient woke up during the night with chills. On the same day, at 02:AM she had difficulty ambulating and at 09:00 AM felt very weak the following day/leg weakness and nausea. The patient was also reported with temperature 99.3 (unspecified units). No further chills. The following day patient felt fine. No treatment was received as a result of events. Patient had not received any other vaccine within four weeks and neither tested with COVID, post vaccination. As per the follow-up (17feb2021), new event nausea was added, event onset times were corrected. Route of administration for both the doses was updated. The outcome of woke up during the night with chills, very weak the following day/leg weakness and nausea was recovered on the same day (17Feb2021) whereas the event difficulty ambulating, temperature 99.3 was recovered on an unspecified date.  Information about lot/Batch number has been requested.  Follow-up (17May2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported for herself in response to non-HCP letter sent which included details like age at vaccination, event onset times, recovery dates and route of drug administration. Drug lot number and expiration date.  Follow-up (28MAY2021): Follow-up attempts completed. No further information expected.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. Concurrent conditions and medical history were not reported. On 25-AUG-2015, the patient was vaccinated with a dose of GARDASIL intramuscular injection, lot # L012190, expiration date 13-APR-2017 (strength, dose series and route not reported), that was inappropriately stored. No adverse effects were reported. This is one of several cases from the same source. Additional information has been requested.
One day after vaccination, developed diffuse erythema multiforme with mild pruritis.  No other symptoms.  Not otherwise ill.  Still has the condition 5 days after the vaccination.
45 minutes post-injection, wrist/thumb started getting sore, then progressed through the night. Pt woke up at 3 AM in extreme pain from thumb/wrist area radiating up arm. Flexing fingers made pain worse. Pt took 1000 mg of acetaminophen and pain was brought down to a 5/10 where she is currently.
Site red about the size of baseball - pt instructed to take Benadryl and use hydrocortisone on the site.
By the middle of the night after receiving the vaccine I woke up with flu like symptoms - cold, chills, fever, body aches. They lasted for about 2 full days. The other side effect I experienced was a severe migraine which lasted for about a week. Also experienced pain/soreness at the injection site but that was actually worse with the first shot than it was with the second.   After those symptoms subsided I experience swollen lymph nodes in my body which were seen in an ultrasound but am unsure if this was unrelated to receiving the vaccine.
Pt recv vax on 4/16/99; 5 min post vax pt exp dizziness, pallor, slumping over
Patient received his second dose too early. Received his first dose on 3/16 and second dose on 3/23 due to having so many vaccines being given at the moment and his confusion (he believed he had to get his second dose that day so he filled out the paperwork for us and turned it in). No adverse events have been reported so far, we do not have an active phone number for this individual.
Menstrual bleeding; large golf ball size swollen gland under left arm; dizziness; nausea; electric shock feeling in head.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Nov2021 15:30 (Lot number: FH8030) at the age of 50 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious) with onset 06Nov2021 23:00, outcome "not recovered", described as "Menstrual bleeding"; LYMPHADENOPATHY (non-serious) with onset 06Nov2021 23:00, outcome "not recovered", described as "large golf ball size swollen gland under left arm"; DIZZINESS (non-serious) with onset 06Nov2021 23:00, outcome "not recovered", described as "dizziness"; NAUSEA (non-serious) with onset 06Nov2021 23:00, outcome "not recovered", described as "nausea"; ELECTRIC SHOCK SENSATION (non-serious) with onset 06Nov2021 23:00, outcome "not recovered", described as "electric shock feeling in head.". Therapeutic measures were not taken as a result of heavy menstrual bleeding, lymphadenopathy, dizziness, nausea, electric shock sensation.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. Known allergy was reported as none. Patient did not receive any other medication within 2 weeks of vaccination. It was unknown if the patient received any other vaccine in four weeks.  Follow-up attempts are completed. No further information is expected.
On the morning of June 18th he felt a burning sensation on the left side of the nose and he observed skin irritation. Over the weekend the area grew to include both sides of the nose and around his left eye. On June 21 he saw a doctor and she diagnosed him with shingles. She then prescribed him Acyclovir 800mg (5xdaily for 10 days). He was fatigued and week most of the week of the 21st. Symptoms left by June 30th.
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A2) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vaccine was stored in freezer, one to two vials were taken out and placed in the fridge each day as needed. No concomitant medication  information were provided. No treatment was given.
Flu like symptoms - high fever - chills - severe body ache - headache - cognitive impairment - lasting 2 days - headache lasting 4 days - on-going cognitive impairment - forgetful/ focus-issues.
Bell's palsy developed 7/02/08; Almost complete, resolved by 8/12/08
pt was monitored for 10 min after vaccine. She had initially felt light headed so she laid down immediately following vaccine. She stated she felt fine and went to the clinic's checkout desk. At that time patient became lightheaded, felt very warm. she sat down and then passed out. She was pale and unresponsive with shallow breathing and a thready pulse. She started to regain consciousness with good breathing and strong pulse,  then passed out again when transferred to wheelchair. After another 30 seconds, she regained full consciousness. Due to an abundance of caution, she was transferred to the emergency room where she was evaluated with CBC and BMP which were both normal. She was given one liter of fluid and monitored for approximately an hour before discharge home with mother.
GUM SWELLING & SERIOUS PAIN, TWO UPPER MOLAR TEETH EXTRACTION ON MID-JULY IN A DENTIST
high fevers 104 very swollen tonsils and sore throat extreme tiredness/sleeping constantly  Dr. assumed Strep throat and started on Amoxil July 6th.  Finished the 10 day course of treatment.  Condition worsened and Dr. started on Keflex July19th.  No improvement and was seen in urgent care July 21st.  Fever of 99.6 at urgent care and heartrate of 132 and very lathargic and weak..  It is determined that he has mono.  He has had mono before but it is explained that possibly the vaccine triggered it to be reactivated in his system.  He is on steroid as of July 21st to try to decrease the inflammation.
Received Dtap to left arm on 9/13/08. Noticed an area of redness 5cm x 4cm with tenderness and warmth to the touch.  Reaction started one day later. No fever. Symptomatic treatment advised.